Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2020

06.10.2020 | Original Research

Effectiveness of Lifestyle and Drug Intervention on Hypertensive Patients: a Randomized Community Intervention Trial in Rural China

verfasst von: Jing Xiao, MD, PhD, Wen-Long Ren, MD, PhD, Yuan-Yuan Liang, MD, Huan Shen, MD, Yue-Xia Gao, MD, PhD, Min-Jie Chu, MD, PhD, Zhou Li, BD, Xiao-Jian Wang, MD, Zuo-Feng Zhang, MD, PhD, Xun Zhuang, MD, PhD, Yong-Fu Yu, MD, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Strict medication guidance and lifestyle interventions to manage blood pressure (BP) in hypertensive patients are typically difficult to follow.

Objective

To evaluate the 1-year effectiveness of lifestyle and drug intervention in the management of rural hypertensive patients.

Design

Randomized community intervention trial.

Participants

The control group comprised 967 patients who received standard antihypertensive drug intervention therapy from two communities, whereas the intervention group comprised 1945 patients who received antihypertensive drug and lifestyle intervention therapies from four communities in rural China.

Main Measures

Data on lifestyle behaviors and BP measurements at baseline and 1-year follow-up were collected. A difference-in-difference logistic regression model was used to assess the effect of the intervention.

Key Results

BP control after the 1-year intervention was better than that at baseline in both groups. The within-group change in BP control of 59.3% in the intervention group was much higher than the 25.2% change in the control group (P < 0.001). Along with the duration of the follow-up period, systolic and diastolic BP decreased rapidly in the early stages and then gradually after 6 months in the intervention group (P < 0.001). In the intervention group, drug therapy adherence was increased by 39.5% (from 48.1% at 1 month to 87.6% at 1 year) (P < 0.001), more in women (45.6%) than in men (31.2%; P < 0.001). The net effect of the lifestyle intervention improved the rate of BP control by 56.1% (70.8% for men and 44.7% for women). For all physiological and biochemical factors, such as body mass index, waist circumference, lipid metabolism, and glucose control, improvements were more significant in the behavioral intervention group than those in the control group (all P < 0.001).

Conclusion

The addition of lifestyle intervention by physicians or nurses helps control BP effectively and lowers BP better than usual care with antihypertensive drug therapy alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRef Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation. 2017;135:e146–603.CrossRef
4.
Zurück zum Zitat Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: A critical step on the pathway to progress. JAMA. 2014;311:21–2.CrossRef Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: A critical step on the pathway to progress. JAMA. 2014;311:21–2.CrossRef
5.
Zurück zum Zitat Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015;372:447–55.CrossRef Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015;372:447–55.CrossRef
6.
Zurück zum Zitat Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141–7.CrossRef Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141–7.CrossRef
7.
Zurück zum Zitat Li W, Gu H, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47000 people from China. J Hypertens. 2016;34:39–46.CrossRef Li W, Gu H, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47000 people from China. J Hypertens. 2016;34:39–46.CrossRef
8.
Zurück zum Zitat Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the international society of hypertension. J Hypertens. 2014;32:3–15.CrossRef Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the international society of hypertension. J Hypertens. 2014;32:3–15.CrossRef
9.
Zurück zum Zitat Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76–99.CrossRef Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76–99.CrossRef
10.
Zurück zum Zitat Whelton SP, Chin A, Xin X, He J. Effects of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.CrossRef Whelton SP, Chin A, Xin X, He J. Effects of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.CrossRef
11.
Zurück zum Zitat Lee CJ, Kim JY, Shim E, et al. The effects of diet alone or in combination with exercise in patients with prehypertension and hypertension: A randomized controlled trial. Korean Circ J. 2018;48:637–51.CrossRef Lee CJ, Kim JY, Shim E, et al. The effects of diet alone or in combination with exercise in patients with prehypertension and hypertension: A randomized controlled trial. Korean Circ J. 2018;48:637–51.CrossRef
12.
Zurück zum Zitat Niiranen TJ, Leino K, Puukka P, Kantola I, Karanko H, Jula AM. Lack of impact of a comprehensive intervention on hypertension in the primary care setting. Am J Hypertens. 2014;27:489–96.CrossRef Niiranen TJ, Leino K, Puukka P, Kantola I, Karanko H, Jula AM. Lack of impact of a comprehensive intervention on hypertension in the primary care setting. Am J Hypertens. 2014;27:489–96.CrossRef
13.
Zurück zum Zitat Friedberg JP, Rodriguez MA, Watsula ME, et al. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015;65:440–6.CrossRef Friedberg JP, Rodriguez MA, Watsula ME, et al. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015;65:440–6.CrossRef
14.
Zurück zum Zitat Parikh A, Lipsitz SR, Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens. 2009;22:409–16.CrossRef Parikh A, Lipsitz SR, Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens. 2009;22:409–16.CrossRef
15.
Zurück zum Zitat Liu LS; Writing Group of Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579–615. [Article in Chinese]PubMed Liu LS; Writing Group of Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579–615. [Article in Chinese]PubMed
16.
Zurück zum Zitat Shu XO, Hatch MC, Mills J, Clemens J, Susser M. Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology. 1995;6:115–20.CrossRef Shu XO, Hatch MC, Mills J, Clemens J, Susser M. Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology. 1995;6:115–20.CrossRef
17.
Zurück zum Zitat Ye F, Wang Y. [Introduction and application of difference-in-differences model]. Chin J Health Stat.. 2013;30:131–4. [Article in Chinese] Ye F, Wang Y. [Introduction and application of difference-in-differences model]. Chin J Health Stat.. 2013;30:131–4. [Article in Chinese]
18.
Zurück zum Zitat Li Y, Wang JL, Zhang XC, et al. Effectiveness of adherence to standardized hypertension management by primary health care workers in China: A cross-sectional survey 3 years after the healthcare reform. Biomed Environ Sci. 2016;29:915–21.PubMed Li Y, Wang JL, Zhang XC, et al. Effectiveness of adherence to standardized hypertension management by primary health care workers in China: A cross-sectional survey 3 years after the healthcare reform. Biomed Environ Sci. 2016;29:915–21.PubMed
19.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–72.CrossRef Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–72.CrossRef
20.
Zurück zum Zitat Daugherty SL, Masoudi FA, Ellis JL, et al. Age-dependent gender differences in hypertension management. J Hypertens. 2011;29:1005–11.CrossRef Daugherty SL, Masoudi FA, Ellis JL, et al. Age-dependent gender differences in hypertension management. J Hypertens. 2011;29:1005–11.CrossRef
21.
Zurück zum Zitat Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21:789–98.CrossRef Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21:789–98.CrossRef
22.
Zurück zum Zitat Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:1142–8.CrossRef Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:1142–8.CrossRef
23.
Zurück zum Zitat Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–24.CrossRef Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117–24.CrossRef
24.
Zurück zum Zitat Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.CrossRef Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.CrossRef
25.
Zurück zum Zitat Miller ER 3rd, Cooper LA, Carson KA, et al. A dietary intervention in urban African Americans: Results of the “five plus nuts and beans” randomized trial. Am J Prev Med. 2016;50:87–95.CrossRef Miller ER 3rd, Cooper LA, Carson KA, et al. A dietary intervention in urban African Americans: Results of the “five plus nuts and beans” randomized trial. Am J Prev Med. 2016;50:87–95.CrossRef
26.
Zurück zum Zitat Kwan MW, Wong MC, Wang HH, et al. Compliance with the dietary approaches to stop hypertension (dash) diet: A systematic review. PLoS One. 2013;8:e78412.CrossRef Kwan MW, Wong MC, Wang HH, et al. Compliance with the dietary approaches to stop hypertension (dash) diet: A systematic review. PLoS One. 2013;8:e78412.CrossRef
27.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925–38.CrossRef Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925–38.CrossRef
28.
Zurück zum Zitat Sharman JE, La Gerche A, Coombes JS. Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens. 2015;28:147–58.CrossRef Sharman JE, La Gerche A, Coombes JS. Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens. 2015;28:147–58.CrossRef
29.
Zurück zum Zitat Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: Role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18:607–13.CrossRef Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: Role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18:607–13.CrossRef
30.
Zurück zum Zitat Li WW, Wallhagen MI, Froelicher ES. Hypertension control, predictors for medication adherence and gender differences in older Chinese immigrants. J Adv Nurs. 2008;61:326–35.CrossRef Li WW, Wallhagen MI, Froelicher ES. Hypertension control, predictors for medication adherence and gender differences in older Chinese immigrants. J Adv Nurs. 2008;61:326–35.CrossRef
31.
Zurück zum Zitat Wong MC, Tam WW, Cheung CS, et al. Medication adherence to first-line antihypertensive drug class in a large Chinese population. Int J Cardiol. 2013;167:1438–42.CrossRef Wong MC, Tam WW, Cheung CS, et al. Medication adherence to first-line antihypertensive drug class in a large Chinese population. Int J Cardiol. 2013;167:1438–42.CrossRef
32.
Zurück zum Zitat Chen SL, Lee WL, Liang T, Liao IC. Factors associated with gender differences in medication adherence: A longitudinal study. J Adv Nurs. 2014;70:2031–40.CrossRef Chen SL, Lee WL, Liang T, Liao IC. Factors associated with gender differences in medication adherence: A longitudinal study. J Adv Nurs. 2014;70:2031–40.CrossRef
33.
Zurück zum Zitat Devkota S, Dhungana RR, Pandey AR, et al. Barriers to treatment and control of hypertension among hypertensive participants: A community-based cross-sectional mixed method study in municipalities of Kathmandu, Nepal Front Cardiovasc Med. 2016;3:26.PubMed Devkota S, Dhungana RR, Pandey AR, et al. Barriers to treatment and control of hypertension among hypertensive participants: A community-based cross-sectional mixed method study in municipalities of Kathmandu, Nepal Front Cardiovasc Med. 2016;3:26.PubMed
34.
Zurück zum Zitat Chen LZ, Shi QT, Ding RJ, Hu DY. [The prevalence, awareness, and control of hypertension in xianghe county of hebei province]. Zhonghua Nei Ke Za Zhi.. 2013;52:185-7. [Article in Chinese]PubMed Chen LZ, Shi QT, Ding RJ, Hu DY. [The prevalence, awareness, and control of hypertension in xianghe county of hebei province]. Zhonghua Nei Ke Za Zhi.. 2013;52:185-7. [Article in Chinese]PubMed
35.
Zurück zum Zitat Feinkohl I, Lachmann G, Brockhaus WR, et al. Association of obesity, diabetes and hypertension with cognitive impairment in older age. Clin Epidemiol. 2018;10:853–62.CrossRef Feinkohl I, Lachmann G, Brockhaus WR, et al. Association of obesity, diabetes and hypertension with cognitive impairment in older age. Clin Epidemiol. 2018;10:853–62.CrossRef
36.
Zurück zum Zitat Xiao J, Hua T, Shen H, et al. Associations of metabolic disorder factors with the risk of uncontrolled hypertension: A follow-up cohort in rural China. Sci Rep. 2017;7:743.CrossRef Xiao J, Hua T, Shen H, et al. Associations of metabolic disorder factors with the risk of uncontrolled hypertension: A follow-up cohort in rural China. Sci Rep. 2017;7:743.CrossRef
37.
Zurück zum Zitat Emamian M, Hasanian SM, Tayefi M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31:e22124.CrossRef Emamian M, Hasanian SM, Tayefi M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31:e22124.CrossRef
Metadaten
Titel
Effectiveness of Lifestyle and Drug Intervention on Hypertensive Patients: a Randomized Community Intervention Trial in Rural China
verfasst von
Jing Xiao, MD, PhD
Wen-Long Ren, MD, PhD
Yuan-Yuan Liang, MD
Huan Shen, MD
Yue-Xia Gao, MD, PhD
Min-Jie Chu, MD, PhD
Zhou Li, BD
Xiao-Jian Wang, MD
Zuo-Feng Zhang, MD, PhD
Xun Zhuang, MD, PhD
Yong-Fu Yu, MD, PhD
Publikationsdatum
06.10.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05601-7

Weitere Artikel der Ausgabe 12/2020

Journal of General Internal Medicine 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.